馃拤馃殌 Moderna and Merck shares surged, with Moderna鈥檚 stock nearly doubling, after strong new trial results for a skin cancer vaccine.
馃拤馃殌 Moderna and Merck shares surged, with Moderna鈥檚 stock nearly doubling, after strong new trial results for a skin cancer vaccine.